Rinri Therapeutics
Biotechnology-Research
Website
Company Tagline
Pioneering the development of first in class cell therapies for sensorineural hearing loss
Industry Category
Business Keywords
Company Description
Rinri Therapeutics is a pioneering biotechnology company dedicated to the development of innovative cell therapies, addressing the critical need for solutions in sensorineural hearing loss. With a focus on regenerative medicine, Rinri Therapeutics strives to restore hearing through the regeneration of damaged sensory cells in the inner ear. Rinri Therapeutics' commitment to advancing biotechnology is evident in its pursuit of disease-modifying therapeutics for sensorineural hearing loss (SNHL) patients, offering hope to over 400 million people worldwide affected by hearing loss. Rinri Therapeutics is located at Primary: 217 Portobello, Sheffield, South Yorkshire S1 4DP, GB.
Rinri Therapeutics is at the forefront of biotechnology research, developing first-in-class cell therapies. Supported by leading investors such as Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, Pioneer Group, and the University of Sheffield, Rinri Therapeutics is well-positioned to deliver groundbreaking advancements in the field. Rinri Therapeutics is committed to excellence and innovation in biotechnology.
Rinri Therapeutics continues to expand its research and development efforts, dedicated to transforming the landscape of hearing loss treatment. Rinri Therapeutics aims to improve the quality of life for millions affected by sensorineural hearing loss. We invite the manager of Rinri Therapeutics to create a customized and exclusive company showcase and product listing on our platform, further enhancing its visibility and reach within the biotechnology community.
Rinri Therapeutics est une entreprise de biotechnologie pionnière dédiée au développement de thérapies cellulaires innovantes, répondant au besoin critique de solutions pour la perte auditive neurosensorielle. En mettant l'accent sur la médecine régénérative, Rinri Therapeutics s'efforce de restaurer l'audition grâce à la régénération des cellules sensorielles endommagées dans l'oreille interne. L'engagement de Rinri Therapeutics à faire progresser la biotechnologie est évident dans sa recherche de traitements modificateurs de la maladie pour les patients atteints de perte auditive neurosensorielle (SNHL), offrant ainsi de l'espoir à plus de 400 millions de personnes dans le monde touchées par la perte auditive. Rinri Therapeutics est située à l'adresse suivante : Primary : 217 Portobello, Sheffield, South Yorkshire S1 4DP, GB.
Rinri Therapeutics est à l'avant-garde de la recherche en biotechnologie, développant des thérapies cellulaires de première classe. Soutenue par des investisseurs de premier plan tels que Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, Pioneer Group et l'Université de Sheffield, Rinri Therapeutics est bien positionnée pour réaliser des avancées révolutionnaires dans le domaine. Rinri Therapeutics s'engage envers l'excellence et l'innovation en biotechnologie.
Rinri Therapeutics continue d'étendre ses efforts de recherche et développement, dans le but de transformer le paysage du traitement de la perte auditive. Rinri Therapeutics vise à améliorer la qualité de vie de millions de personnes touchées par la perte auditive neurosensorielle. Nous invitons le responsable de Rinri Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, améliorant ainsi sa visibilité et sa portée au sein de la communauté biotechnologique.
Key Personnel / Employees
Compare Companies Side by Side
Compare Rinri Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Rinri TherapeuticsMain Company |
Es
EsoBiotecView Profile |
Skin2NeuronView Profile |
Taiwan Bio Therapeut...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2020 | 2019 | 2014 |
|
Company Size
|
— | 11-50 | 2-10 | 51-200 |
|
City
|
Sheffield, South Yorkshire | Sydney, New South Wales | Hsinchu County, Taiwan (R.O.C.) | |
|
Country
|
United Kingdom | Australia | ||
|
Skills & Keywords
Comparing with main company
|
9 Total Skills
Biotechnology
Cell Therapy
Regenerative Medicine
Sensorineural Hearing Loss
Hearing Restoration
Advanced Therapy
Pharmaceuticals
Cell therapy
Hearing loss
|
6 Total
6 Unique
Unique Skills:
Cancer
Gene therapy
Immunology
in vivo engineering
Oncology
virology
|
4 Total
1 Common
3 Unique
Match
11%
Common Skills:
Regenerative Medicine
Unique Skills:
Alzheimer's disease
Medical Research
Stem Cells
|
5 Total
5 Unique
Unique Skills:
CAR-T
CDMO/CMO
Functional Assays
Gene Modifield
MSC
|
4
Total Companies2014
Oldest Founded2
Countries23
Unique SkillsSimilar Companies
Other organizations in the same industry
Fusion Antibodies
Biotechnology-ResearchAntibody Services from Discovery to Clinical Supply
Exploristics | Transforming Clinical Trial Design
Biotechnology-ResearchKerusCloud clinical trial optimization software, biostatistics consulting, synthetic data generation...
ARC Regulatory
Biotechnology-ResearchARC is a specialist regulatory and clinical research company dedicated to the Precision Medicine, IV...
Alternative Company Names
This company is also known as